TherapeuticsMD
TXMD
#10731
Rank
ยฃ15.12 M
Marketcap
ยฃ1.31
Share price
-5.52%
Change (1 day)
3.62%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2026 (TTM): ยฃ0.05895

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is ยฃ0.06113. In 2021 the company made an earnings per share (EPS) of -ยฃ16.58 an increase over its 2020 EPS that were of -ยฃ25.60.

EPS history for TherapeuticsMD from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.05895
2021-ยฃ16.58-35.22%
2020-ยฃ25.60-5.63%
2019-ยฃ27.1320.34%
2018-ยฃ22.5455.26%
2017-ยฃ14.52-19.15%
2016-ยฃ17.96-6%
2015-ยฃ19.1042.86%
2014-ยฃ13.3752.17%
2013-ยฃ8.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54 787.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ4.47 7,214.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-ยฃ2.96-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.17 1,811.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-ยฃ19.32-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA